CD8A and neoplasm: In a rat model, Wang et al. found that anti-PD-L1 therapy, in combination with BCG, significantly decreases tumor weight, upregulates tumor infiltrating CD8+ T cells, causes them to produce significantly more granzyme B, INF-γ and TNF-α, and decreases myeloid-derived suppressor cells [147].